• Jeff Galvin, CEO & Founder, American Gene Technologies (AGT), joins Rich Bendis on BioTalk

    Jeff Galvin, CEO & Founder, American Gene Technologies (AGT), joins Rich Bendis on BioTalk

  •  RegenxBio raises $175.5M follow-on - BioCentury

    RegenxBio raises $175.5M follow-on - BioCentury

  • Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax

    Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax

  •  Investment Boom in MoCo

    Investment Boom in MoCo

  • Quality Biological, Inc. (QBI) President and CEO Angela Graham joins Rich Bendis for New Episode of BioTalk

    Quality Biological, Inc. (QBI) President and CEO Angela Graham joins Rich Bendis for New Episode of BioTalk

  • Cardin Announces Several Small Business Priorities in National Defense Bill | U.S. Senator Ben Cardin of Maryland

    Cardin Announces Several Small Business Priorities in National Defense Bill | U.S. Senator Ben Cardin of Maryland

  • Rip Ballou, MD, VP & Head, GSK Global Vaccines US R&D Center, joins host Rich Bendis on a new episode of BioTalk

    Rip Ballou, MD, VP & Head, GSK Global Vaccines US R&D Center, joins host Rich Bendis on a new episode of BioTalk

  • BHI CEO Rich Bendis' Opening Presentation at The 2018 BioHeath Capital Region Forum

    BHI CEO Rich Bendis' Opening Presentation at The 2018 BioHeath Capital Region Forum

  • Brian Gaines, Chief Executive Officer of the MdBio Foundation, joins BioTalk host Rich Bendis to discuss STEM Education, Workforce Development, Funding, and expanding beyond the BioHealth Capital Region

    Brian Gaines, Chief Executive Officer of the MdBio Foundation, joins BioTalk host Rich Bendis to discuss STEM Education, Workforce Development, Funding, and expanding beyond the BioHealth Capital Region

  • Matt Mulvey, Co-Founder and CEO of BeneVir, sits down with host Rich Bendis to discuss Funding, Licensing, and their new relationship with J&J

    Matt Mulvey, Co-Founder and CEO of BeneVir, sits down with host Rich Bendis to discuss Funding, Licensing, and their new relationship with J&J

  • Biohealth Capital Region aiming for top 3 status - Smart Incentives

    Biohealth Capital Region aiming for top 3 status - Smart Incentives